Veerix Biotech is a WHO-GMP certified third-party pharmaceutical manufacturer and CDMO partner producing VEERIX-TRYPSIN Tablets (TRYPSIN, BROMELAIN & RUTOSIDE TRIHYDRATE TOTAL PROTEOYTIC ACTIVITY NOT LESS THAN 1095 FIP UNITS / TABLETS (PAPAIN METHOD) ENTERIC COATED TABLET) within the Others therapeutic class, with complete Certificate of Analysis (CoA), stability studies, and regulatory dossier compliance for domestic Indian and global export markets.
| Product Name | VEERIX-TRYPSIN Tablets |
| Active Composition | TRYPSIN, BROMELAIN & RUTOSIDE TRIHYDRATE TOTAL PROTEOYTIC ACTIVITY NOT LESS THAN 1095 FIP UNITS / TABLETS (PAPAIN METHOD) ENTERIC COATED TABLET |
| Therapeutic Segment | Others |
| Dosage Form | Tablets |
| Primary Packaging | 10*10 Tablets |
| Quality Standard | IP / BP / USP Pharmacopeial Standard, WHO-GMP Certified |
| Manufacturing Facility | Tahliwal Industrial Area, Tehsil Haroli, Una, Himachal Pradesh & Coimbatore, Tamil Nadu |
| Regulatory Documentation | Batch Release CoA, Method of Analysis (MOA), Accelerated & Real-time Stability Data, CTD Module 3 |
Veerix Biotech provides end-to-end commercial supply and technical scoping for VEERIX-TRYPSIN Tablets in the Others class. From pre-formulation screening and pilot batch validation to automated blister packaging, serialisation, and multi-market regulatory clearance, our direct facilities and audited partner network ensure seamless execution.